Phase II study of copanlisib, a PI3K inhibitor, in relapsed...

  • Main
  • 2017 / 06
  • Phase II study of copanlisib, a PI3K inhibitor, in relapsed...
Annals of Oncology 2017 / 06

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

Dreyling, M., Morschhauser, F., Bouabdallah, K., Bron, D., Cunningham, D., Assouline, S. E., Verhoef, G., Linton, K., Thieblemont, C., Vitolo, U., Hiemeyer, F., Giurescu, M., Garcia-Vargas, J., Gorbat
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx289
Date:
June, 2017
File:
PDF, 1.21 MB
english, 2017
Conversion to is in progress
Conversion to is failed